All HHS Contracts — April 23, 2026

Small business Emergent BioDefense Operations Lansing LLC received a non-competed firm fixed price contract for $211,409,788 (potential $647.5M with options) from BARDA for Chimerix smallpox antiviral R&D, with $173.9M already outlayed through 2028-2032.

Maximus Federal Services, Inc. secured a fully competed labor hours delivery order for $71,229,539 (potential $91.5M ceiling) from CDC for telemarketing services, with $46.5M outlayed through 2026.

Emergent BioDefense Operations Lansing LLC's firm fixed price contract carries high pricing risk, with $211.4M obligated but performance spanning to 2032 and options unexercised.

DLA Troop Support's $65M firm fixed price pharmaceuticals contract to HHS/NIH has $0 outlayed despite 2026-04-09 award, signaling execution delays in future-dated DoD-related procurement.

Experian Information Solutions, Inc.'s $44M firm fixed price CMS contract for remote identity proofing has high pricing risk, with $32.2M outlayed but non-competitive structure.

Emergent BioDefense Operations Lansing LLC's non-competed BARDA award signals agency confidence in its biodefense capabilities for smallpox antiviral R&D.

Maximus Federal Services, Inc. has unexercised options adding $20.3M to its $71.2M CDC contact center order.

Noridian Healthcare Solutions, LLC's cost-plus CMS Medicare DME contract has potential to $184M from current $64.6M obligation through 2031.

BARDA's $211.4M non-competed award to Emergent BioDefense Operations Lansing LLC for smallpox antiviral underscores sustained biodefense funding with long-duration performance to 2032.

CMS awarded $64.6M to Noridian Healthcare Solutions, LLC and $44M to Experian Information Solutions, Inc. for DME claims and identity proofing, with long terms to 2031 and 2026.

{"entity"=>"Emergent BioDefense Operations Lansing LLC", "reason"=>"$211.4M BARDA contract with $173.9M outlayed and $647.5M potential", "trigger"=>"Options exercise; outlay beyond $173.9M; end 2028-10-01"}

{"entity"=>"Maximus Federal Services, Inc.", "reason"=>"$71.2M CDC order with $46.5M outlayed and $91.5M ceiling", "trigger"=>"Option exercises; performance to 2026-08-31"}

{"entity"=>"DLA Troop Support", "reason"=>"$65M HHS/NIH pharmaceuticals with $0 outlayed, defense-related", "trigger"=>"Outlays initiation; start 2026-04-10"}

{"entity"=>"Noridian Healthcare Solutions, LLC", "reason"=>"$64.6M CMS Medicare contract toward $184M potential", "trigger"=>"Option exercises; outlays vs $33.7M"}